But if your question is which one currently has the stronger science-driven weight-loss case , retatrutide has the edge
This study indicates that GLP-1 receptor agonists may be linked to a higher risk of smell and taste disturbances, study co-author Nir Zontag told Gizmodo
Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM
Clinical trials have shown tirzepatide produces greater average weight loss, though individual results vary
Once a drug is on the market, millions of patients might take it for years
Careful consideration of these factors allows researchers to craft an informed retatrutide dosage schedule after high dose of tirzepatide that maximizes scientific rigor